Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.

MLA

Stewart, James Peter, et al. “Validation of the EuroClonality-NGS DNA Capture Panel as an Integrated Genomic Tool for Lymphoproliferative Disorders.” Blood Advances, vol. 5, no. 16, Aug. 2021, pp. 3188–98. EBSCOhost, https://doi.org/10.1182/bloodadvances.2020004056.

APA

Stewart, J. P., Gazdova, J., Darzentas, N., Wren, D., Proszek, P., Fazio, G., Songia, S., Alcoceba, M., Sarasquete, M. E., Villarese, P., van der Klift, M. Y., Heezen, K. C., McCafferty, N., Pal, K., Catherwood, M., Kim, C. S., Srivastava, S., Kroeze, L. I., Hodges, E., … Gonzalez, D. (2021). Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders. Blood Advances, 5(16), 3188–3198. https://doi.org/10.1182/bloodadvances.2020004056

Chicago

Stewart, James Peter, Jana Gazdova, Nikos Darzentas, Dörte Wren, Paula Proszek, Grazia Fazio, Simona Songia, et al. 2021. “Validation of the EuroClonality-NGS DNA Capture Panel as an Integrated Genomic Tool for Lymphoproliferative Disorders.” Blood Advances 5 (16): 3188–98. doi:10.1182/bloodadvances.2020004056.